U.S. flag

An official website of the United States government

NM_006231.4(POLE):c.1270C>G (p.Leu424Val) AND Colorectal cancer, susceptibility to, 12

Germline classification:
risk factor (1 submission)
Last evaluated:
Aug 1, 2015
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000033144.15

Allele description [Variation Report for NM_006231.4(POLE):c.1270C>G (p.Leu424Val)]

NM_006231.4(POLE):c.1270C>G (p.Leu424Val)

Gene:
POLE:DNA polymerase epsilon, catalytic subunit [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
12q24.33
Genomic location:
Preferred name:
NM_006231.4(POLE):c.1270C>G (p.Leu424Val)
HGVS:
  • NC_000012.12:g.132673664G>C
  • NG_033840.1:g.18861C>G
  • NM_006231.4:c.1270C>GMANE SELECT
  • NP_006222.2:p.Leu424Val
  • NP_006222.2:p.Leu424Val
  • LRG_789t1:c.1270C>G
  • LRG_789:g.18861C>G
  • LRG_789p1:p.Leu424Val
  • NC_000012.11:g.133250250G>C
  • NM_006231.2:c.1270C>G
  • NM_006231.3:c.1270C>G
  • Q07864:p.Leu424Val
Protein change:
L424V; LEU424VAL
Links:
UniProtKB: Q07864#VAR_069344; OMIM: 174762.0001; dbSNP: rs483352909
NCBI 1000 Genomes Browser:
rs483352909
Molecular consequence:
  • NM_006231.4:c.1270C>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Colorectal cancer, susceptibility to, 12 (CRCS12)
Synonyms:
COLORECTAL CANCER, SUSCEPTIBILITY TO, ON CHROMOSOME 12q24
Identifiers:
MONDO: MONDO:0014038; MedGen: C3554460; Orphanet: 220460; OMIM: 615083

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000056926OMIM
no assertion criteria provided
risk factor
(Aug 1, 2015)
unknownliterature only

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownnot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.

Palles C, Cazier JB, Howarth KM, Domingo E, Jones AM, Broderick P, Kemp Z, Spain SL, Guarino E, Salguero I, Sherborne A, Chubb D, Carvajal-Carmona LG, Ma Y, Kaur K, Dobbins S, Barclay E, Gorman M, Martin L, Kovac MB, Humphray S; CORGI Consortium.; et al.

Nat Genet. 2013 Feb;45(2):136-44. doi: 10.1038/ng.2503. Epub 2012 Dec 23. Erratum in: Nat Genet. 2013 Jun;45(6):713. Guarino Almeida, Estrella [corrected to Guarino, Estrella].

PubMed [citation]
PMID:
23263490
PMCID:
PMC3785128

New insights into POLE and POLD1 germline mutations in familial colorectal cancer and polyposis.

Valle L, Hernández-Illán E, Bellido F, Aiza G, Castillejo A, Castillejo MI, Navarro M, Seguí N, Vargas G, Guarinos C, Juarez M, Sanjuán X, Iglesias S, Alenda C, Egoavil C, Segura Á, Juan MJ, Rodriguez-Soler M, Brunet J, González S, Jover R, Lázaro C, et al.

Hum Mol Genet. 2014 Jul 1;23(13):3506-12. doi: 10.1093/hmg/ddu058. Epub 2014 Feb 5.

PubMed [citation]
PMID:
24501277
See all PubMed Citations (3)

Details of each submission

From OMIM, SCV000056926.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (3)

Description

In affected members of a family with susceptibility to colorectal cancer-12 (CRCS12; 615083), Palles et al. (2013) identified a heterozygous 1270C-G transversion in the POLE gene, resulting in a leu424-to-val (L424V) substitution at a highly conserved residue in the active site of the exonuclease (proofreading) domain. The mutant mRNA was stably expressed. Molecular modeling using yeast structures indicated that the L424V mutation will distort the packing of helices involved at the exonuclease active site, likely affecting nuclear activity. The mutation was identified by linkage analysis combined with whole-genome sequencing. Direct screening for this mutation in 3,805 individuals of European ancestry with a familial colorectal cancer, multiple adenomas, and early-onset disease resulted in the identification of 12 additional unrelated probands with the mutation. The mutation was not found in 6,721 control individuals or in 10,755 control exomes. The mutation segregated with the phenotype in each of the families; there was no evidence for a common ancestor. The phenotype was compatible with autosomal dominant inheritance of a high-penetrance predisposition to the development of colorectal adenomas and carcinomas, with a variable tendency to develop multiple and large tumors. The histologic features of the tumors were unremarkable, and all were microsatellite stable. Some tumors had additional somatic mutations, for example, in the APC (611731) or KRAS (190070) genes.

Valle et al. (2014) identified a de novo heterozygous L424V mutation in the POLE gene in a 28-year-old woman with polyposis and colorectal cancer. No loss of heterozygosity at the POLE chromosomal region was found in tumor DNA. This patient was ascertained from a cohort of 858 Spanish probands with familial/early-onset CRC who underwent screening of the POLE gene, thus accounting for 0.12% of the total.

Elsayed et al. (2015) identified heterozygosity for the c.1270C-G transversion (c.1270C-G, NM_006231.2) in the POLE gene, resulting in a L424V mutation, in 3 (0.25%) of 1,188 Dutch index patients with polyposis or familial colorectal cancer. In 1 patient, the mutation occurred de novo. Tumor tissue samples available from 3 patients from 2 families showed microsatellite instability and were found to have somatic mutations in the MSH2 (609309) and/or MSH6 (600678) genes. The findings indicated that POLE DNA analysis is warranted in microsatellite-unstable colorectal cancer, especially in the absence of a germline variant in DNA Mismatch repair genes.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownnot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 15, 2024